Floatz logo

Idazoxan

Molecular Imaging

Imperial College LondonSmall moleculeEarly Phase 1Dormant
CC
40/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
25/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Molecular Imaging cohort.

Asset / SponsorPhaseRating
Isocarboxazid
Imperial College London
Early Phase 1CC
18F-MPG
Harbin Medical University
N/AD

Same molecule, other indications

Idazoxan is also rated in:

major depressive disorderDormant
CC
Indicative ·
45 / 100
View asset →
Healthy VolunteersDormant
C
Indicative ·
39 / 100
View asset →
Alzheimer diseaseDormant
C
Indicative ·
35 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →